COVID-19–related outcomes poor for patients with hematologic disease in ASH registryDecember 5, 2020COVID-19 UpdatesALLMultiple MyelomaB Cell LymphomaNon-Hodgkin Lymphoma
Home care for bortezomib safe and reduces hospital visits in myeloma patientsNovember 11, 2020Multiple Myeloma
Initial response to novel agents preps MM patients for favorable transplant outcomesSeptember 24, 2020Multiple Myeloma
Survey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesDLBCLAggressive LymphomasALLAMLAnemiaCLL
Elotuzumab-based therapy may benefit post-transplant response in multiple myelomaAugust 12, 2020Multiple Myeloma
MM patients with concurrent AL show poor survival when coupled to cardiac dysfunctionJuly 23, 2020Multiple MyelomaMixed Topics
Transitioning regimen may prolong proteasome inhibitor–based therapy for MMJuly 9, 2020Multiple Myeloma
Tandem transplantation, long-term maintenance may extend MM remissionJune 11, 2020Multiple MyelomaTransplantMixed Topics
